Archived Webinar: State of the Art in Hepatitis C Virus (HCV) Infection Diagnosis and Treatment
Archived Webinar:
State of the Art in Hepatitis C Virus (HCV) Infection Diagnosis and Treatment
Kristen M. Marks, MD
Release date: April 17, 2018
Expiration date: April 17, 2019
CME Credit Available: No longer available for CME credit
Overview
Assessment of Needs
The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HCV disease as part of a nationwide continuing medical education (CME) effort for physicians.
This webinar will utilize patient case scenarios to lead both novice and experienced practitioners through the diagnosis, workup, and recommended treatment of HCV. The most recently approved treatment regimens will be highlighted as well as treatment strategies for patients with HIV infection and renal disease.
Learning Objectives
Upon completion of this webinar, learners will be able to:
- Recognize diagnostic testing strategies for HCV and when to do testing for HCV resistance
- Describe regimens recommended for initial treatment of HCV infection
- Identify the advantages and limitations of newly approved HCV treatment regimens
Registration
Who Should Attend
This webinar is designed for physicians who have a good understanding of the basics of HCV transmission, testing, and management, and have managed HCV infection in at least 5 patients.
This activity is also relevant for registered nurses, PharmDs, and other health professionals.
Please note: if you already have participated on the live webinar and have received CME credits, you will not receive additional credits from this activity
Conflicts of Interest
In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.
Continuing Education Credits
CME Credits
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Grant Support
This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from commercial companies. Per IAS–USA policy, any effort that uses commercial grants must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.
PLATINUM SUPPORTER
Gilead Sciences, Inc
BRONZE SUPPORTER
AbbVie
ADDITIONAL SUPPORT
Merck
Frequently Asked Questions
View our list of FAQs about attending a webinar.
Further Questions?
Please contact the registration department at registration“at”iasusa.org or 415-544-9400.
By clicking the link below, I acknowledge that I have read these instructions and understand them.
You must log in to take the activity.